期刊文献+

小鼠肺腺癌细胞C-erbB-2基因片段TA克隆载体的构建与鉴定

Construction and identification of TA cloning vecter of murine lung cancer cell C-erbB-2 gene fragments
下载PDF
导出
摘要 目的:选择C-erbB-2(neu)基因中编码两个HLA-A2限制性CTL抗原肽表位p106-114,p369-377的基因片段,构建克隆载体pGM-neu1(包含p106-114片段)和pGM-neu2(包含p369-377片段)。方法:用免疫组化方法检测小鼠Lewis肺腺癌细胞中C-erbB-2的表达,然后采用RT-PCR技术,从小鼠Lewis肺腺癌细胞总RNA中扩增编码neu1(包含p106-114片段)、neu2(包含p369-377片段)的基因片段,通过连接反应构建重组克隆载体,测序鉴定。结果:免疫组化染色检测C-erbB-2的表达,发现小鼠Lewis肺腺癌细胞有明显深棕色,表现出较强阳性,阳性信号位于细胞膜。RT-PCR扩增产物neu1、neu2基因片段大小与理论预期相符。重组克隆载体经DNA序列测定,结果与GeneBank中小鼠C-erbB-2的基因序列一致。结论:C-erbB-2在小鼠Lewis肺腺癌细胞中有较高表达,成功构建了克隆载体pGM-neu1和pGM-neu2。 Objective: To construct and identify TA cloning vector of C-erbB-2 gene fragments. Methods: The detection of C-erbB-2 in murine Lewis lung cancer cell was carried out by immunohistochemistry.The 164bp region of neul cDNA and 157bp region of neu2 eDNA were amplified by RT-PCR from murine Lewis lung cancer cell total RNA. The PCR products were cloned into TA cloning vector. Sequence analysis was carried out. Results: C-erbB-2 was positive in all murine Lewis lung cancer cells, and the signal mainly located in the membrane of Lewis cells.Prospective amplified products-neul 164bp and neu2 157bp gene were obtained by RT- PCR method.The TA cloning vectors were identified as neul and neu2 with the sequencing methods. Conclusion: The expression of C-erbB-2 gene in murine Lewis lung cancer cell was high. pGM-neul and pGM-neu2 cloning vector were successfully constructed.
出处 《泸州医学院学报》 2013年第1期39-42,共4页 Journal of Luzhou Medical College
基金 四川省卫生厅项目(0602010)
关键词 C-ERBB-2 肺腺癌 克隆 T载体 C-erbB-2 Lung adenocarcinoma Cloning T vector
  • 相关文献

参考文献11

  • 1CB Nunes, RM Rocha, JS Reis-Filho.Comparative anal- ysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas[J].Clin Pathol,2008, 61:934-938.
  • 2Ellis M J. Neoadjuvant endocrine therapy for breast cancer: more questions than answers[J]. Journal of Clinical Oncol- ogy, 2005,23(22): 4842-4844.
  • 3MC Durdn, F Vega, G Moreno - Bueno. Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer [J], PRO- TEOMICS-Clinical Applications, 2008,2(9): 1313-1326.
  • 4R Singh, Y Paterson. Vaccination strategy determines the emergence and Dominance of CD8^+ T-cell epitopes in a FVB/N rat HER-2/neu mouse model of breast cancer [J].Cancer Res,2006,1(66): 7748-7750.
  • 5ML Disis, V Goodell, K Schiffman. Humoral Epitope- spreading following immunization with a HER-2/neu peptide based vaccine in cancer Patients [J].Clinical Imm- unology,2004,5 (24):571-578.
  • 6MA Morse, J Wei, Z Hartman,et al. Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo [J]. International Journal of Cancer,2010,126 (12):2893-2903.
  • 7Dimitriadis A,Gontinou C,Baxevanis CN,et al.The man- nosylated extracellular domain of HER-2/neu produced in P.pastoris induces protective antitumor immunity [J]. BMC cancer,2009,9:386-389.
  • 8Seavey MM,Pan ZK,Maciag PC, et al.A novel human HER-2/neu chimeric molecule expressed by listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of HER-2/neu-positive breast tumors[J]. Clin Cancer Res,2009,15 (3):924-932.
  • 9Ishizawar R, Parsons S. c-Src and cooperating partners in human cancer[J].Cancer Cell,2004,6(3):209-214.
  • 10Li XJ, Liang JR, Wu M, et al. Expression and clinical sig- nificance of epidermal growth factor receptor and C- erbB2 oncoprotein in non-small cell lung cancer [J]. Chin J Xi 'an Jiaotong University (Medical Sciences), 2003, 24 (2):150-153.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部